Skip to main content

Wisdom

JAMA: RCT in 101 chronic low back pain pts showed a single nondeceptive placebo injection reduced LBP intensity for 1 month https://t.co/RI9TnvmeMJ https://t.co/BF6UBqMXrD
Dr. John Cush @RheumNow( View Tweet )

ACR Recommends QOL Self-Management Strategies

ACR

American College of Rheumatology (ACR) experts identified research suggesting that patient self-management is

Read Article

Moving Forward on RA Prevention Trials

Now that multiple prevention clinical trials for rheumatoid arthritis (RA) have been completed, a group of investigators have reviewed the results and published their recommendations for future trial designs and drug development to assess interventions that may alter disease development.

Read Article

Good Clinical Practice Recommendations on Glucocorticoid Withdrawal and Adrenal Insufficiency

Glucocorticoids are widely prescribed as anti-inflammatory and immunosuppressive agents. This results in at least 1% of the population using chronic glucocorticoid therapy being at risk for glucocorticoid-induced adrenal insufficiency. This risk is dependent on the dose, duration and potency of

Read Article

Running with Data (8.30.2024)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com - including tips on steroids, MAS, and myositis testing.

Read Article

A Family History of Arthritis?

Using data from the population based All of Us (AoU) Research Program, a self reported history of arthritis and related conditions was associated with an increased risk for arthritis, osteoporosis, and carpal tunnel syndrome.

Read Article
Depends on Where You’re Looking (8.9.2024) https://t.co/GDAN37DJSx https://t.co/jVoumC00r5
Dr. John Cush @RheumNow( View Tweet )

Barriers to Treat-to-Target in Rheumatoid Arthritis

A systematic and scoping literature examined the Treat-to-target (T2T) approach to rheumatoid arthritis (RA), noting its implementation is suboptimal and finding many barriers to implementation.

Read Article
2024 EULAR Points to consider when treating patients with cancer https://t.co/oXO8m8mrfJ https://t.co/v69zPteDr0
Dr. John Cush @RheumNow( View Tweet )

Decline in Physician Trust During the COVID-19 Pandemic

JAMA reports that following the COVID-19 pandemic US adults trust in physicians and hospitals decreased, and was associated with lower odds of COVID vaccination.

Read Article
Location, Location, Location (7.26.2024) Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. Location matters; Geo-rheumatology? https://t.co/I81qpckOQG https://t.co/cyu64ThPkN
Dr. John Cush @RheumNow( View Tweet )
Whats it like to be a Rheum? AMA shadows 11 yr rheumatologist Dr. Amish Dave - typical day, challenging aspects, burnout, lifestyle, skills, insights and med student advice - Thanks Dr. Dave!! https://t.co/AIfWwb4HpG https://t.co/EvFVAeqWfK
Dr. John Cush @RheumNow( View Tweet )
We don't need to debate whether it's better to be a generalist or a specialist. The world needs both. Specialists excel at zooming in. They see the details to deepen our knowledge. Generalists excel at zooming out. They see around corners to broaden our view. https://t.co/muATPY2vUL
Adam Grant @AdamMGrant( View Tweet )

Digital Self Screening for Arthritis Diagnosis

There are numerous impediments to diagnosis or referral; and a new study evaluates patient use of a mobile artificial intelligence (AI)–based symptom checker for diagnoses, but demonstrated only modest accuracy when applied to a cohort of patients with joint symptoms.

Read Article
Whats it like to be a Rheum? AMA shadows 11 yr rheumatologist Dr. Amish Dave - typical day, challenging aspects, burnout, lifestyle, skills, insights and med student advice - Thanks Dr. Dave!! https://t.co/NY44hhjTYA https://t.co/809RBgSokM
Dr. John Cush @RheumNow( View Tweet )
EULAR 2024 Recommendations on Reproductive Health https://t.co/QuXQlpQv8O https://t.co/nHC7LOLLl8
Dr. John Cush @RheumNow( View Tweet )

ICYMI: Can Mycophenolate be Stopped in Stable SLE?

In patients with clinically stable systemic lupus erythematosus (SLE) and lupus nephritis, the withdrawal of mycophenolate mofetil was not significantly inferior to mycophenolate maintenance, but MMF withdrawal had numerically more reactivations, while MMF maintenance had more infections.

Read Article

ICYMI: Best Imaging in Giant Cell Arteritis - US, PET, MRI?

Imaging is often instrumental in diagnosing and staging patients diagnosed with giant cell arteritis. A new study compared the diagnostic performance of Colour Duplex Ultrasound (CDUS), Fluor-18-deoxyglucose Positron Emission Tomography Computed Tomography and Magnetic Resonance Imaging in

Read Article

ICYMI: JAMA: SLE Review

Drs. Caroline Siegel and Lisa Sammaritano (from HSS in NYC) have published an impressive overview of systemic lupus erythematosus (SLE) in JAMA. This timely, well-written review covers the many complexities of this multi-organ disorder that affects nearly 3.4 million people worldwide.

Read Article

Factors Affecting Hydroxychloroquine Adherence

A study from the University of British Columbia has evaluated the trajectories of hydroxychloroquine (HCQ) use in patients with incident RA and SLE between1997 and 2021, and identified factors associated with high adherence. 

From a total of 27,510 RA/SLE patients taking

Read Article

Low Back Pain? Take a Walk!

A randomised controlled trial of adults with recurrent low back pain (LBP) has shown that a program of progressive walking and education intervention significantly reduced low back pain recurrence.

Read Article

No Risk of Interstitial Lung Disease with Methotrexate Use

JAMA reports a cohort study that investigated the association between methotrexate (MTX) use and Interstitial lung disease (ILD) in patients with dermatomyositis (DM).

Read Article
The art of talking about risks with our patients https://t.co/V0JQ1EsbKc https://t.co/GSTbPu0EXZ
Dr. John Cush @RheumNow( View Tweet )

EULAR 2024 – Day 2 Report (A Difficult RA Day)

Day 2 at EULAR 2024 was a big poster day for many with several good sessions and oral presentations on Preventing RA, new vasculitis therapies and a session devoted to the 50th anniversary of the Moll & Wright Criteria.

Read Article